Levothyroxine Zentiva

Levothyroxine Sodium, the active ingredient in Levothyroxine Zentiva, is a thyroid hormone replacement presented as a tablet for oral use. It provides exogenous thyroxine (T4) to compensate for deficient endogenous hormone, thereby normalizing metabolic activity in patients diagnosed with hypothyroidism, goiter, or requiring hormone replacement following thyroidectomy.

GNH USA supplies Levothyroxine Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑assured product availability across global markets. The company adheres to EU GMP standards and provides regulatory documentation to support import and clinical use.

Levothyroxine Zentiva is used in thyroid hormone replacement therapy to correct deficient thyroid function.

- Hypothyroidism: restores normal thyroid hormone levels, alleviating symptoms such as fatigue, weight gain, and cold intolerance. - Goiter: reduces thyroid gland enlargement by normalizing hormone feedback mechanisms. - Post‑thyroidectomy: provides necessary thyroxine to maintain metabolic balance after surgical removal of the thyroid.

Levothyroxine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: mild to moderate headache may occur, especially after dose changes. - Insomnia: difficulty sleeping can be reported, often related to excess hormone levels. - Palpitations: sensation of rapid or irregular heartbeat. - Heat intolerance: increased sensitivity to warm environments. - Tremor: fine shaking of hands or limbs. - Weight loss: unintended loss of body weight.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or throat requiring immediate medical attention. - Chest pain: may indicate cardiac ischemia, especially in patients with coronary disease. - Arrhythmia: abnormal heart rhythms, including atrial fibrillation. - Severe allergic reaction: rash, itching, or anaphylaxis. - Osteoporosis: long‑term excess hormone may reduce bone mineral density.

Before initiating therapy, several safety considerations should be reviewed.

- Dose adjustment: monitor serum TSH and free T4 levels and titrate dose accordingly. - Cardiovascular disease: use caution in patients with coronary artery disease or arrhythmias. - Pregnancy: evaluate risk‑benefit ratio; levothyroxine is generally continued if already prescribed. - Elderly: start with a lower dose and increase gradually to avoid overtreatment. - Drug interactions: review concomitant medications that may affect absorption or metabolism. - Store at room temperature: keep in the original container, protect from moisture and light.

Levothyroxine can interact with several medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Amiodarone: may increase thyroid hormone levels, risking thyrotoxicosis. - Warfarin: levothyroxine can enhance anticoagulant effect, requiring INR monitoring. - Antacids/Calcium carbonate: reduce levothyroxine absorption; separate dosing by at least 4 hours.

Moderate Interactions (Monitor Closely): - Estrogen therapy: may increase levothyroxine requirement. - Cholestyramine: can decrease levothyroxine absorption. - Beta‑blockers: may mask symptoms of excess thyroid hormone.